Liquidia (LQDA) Payables (2019 - 2026)
Liquidia (LQDA) posted Payables of $12.7 million for Q2 2026, up 16.09% on a QoQ basis from $11.0 million in Q1 2026, and up 12.36% year-over-year from $11.3 million in Q2 2025.
Analysis
Liquidia (LQDA) Payables (2019 - 2026) Analysis & Trends
Liquidia has reported Payables for 8 years, with the latest figure at $12.7 million in Q2 2026.
- On a quarterly basis, Payables rose 12.36% year-over-year to $12.7 million in Q2 2026; TTM through Jun 2026 was $12.7 million, a 12.36% increase from a year earlier, with the FY2025 full-year figure at $3.7 million, down 21.56% from the prior year.
- Payables was $12.7 million for Q2 2026 at Liquidia, up from $11.0 million in the prior quarter.
- The five-year high for Payables was $12.7 million in Q2 2026, with the low at $841000.0 in Q1 2023.
- Average Payables over 5 years is $4.5 million, with a median of $2.4 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2025: Payables plunged 49.52% in 2023, then soared 248.39% in 2025.
- Over 5 years, Payables stood at $2.2 million in 2022, then plunged by 36.46% to $1.4 million in 2023, then soared by 235.89% to $4.7 million in 2024, then decreased by 21.56% to $3.7 million in 2025, then surged by 246.6% to $12.7 million in 2026.
- The last three Payables figures came in at $12.7 million (Q2 2026), $11.0 million (Q1 2026), and $3.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 442.18 Bn | 435.61 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 366.59 Bn | 359.45 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 266.49 Bn | 258.80 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Pfizer | 159.09 Bn | 147.39 Bn | 10.94 Bn | 7.03 Bn |
| 6 | Sanofi | 52.34 Bn | 44.96 Bn | 10.79 Bn | 8.31 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 88.42 Mn |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 250.40 Mn |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn | 497.80 Mn |
| 10 | Liquidia | 6.12 Bn | 5.83 Bn | 160.92 Mn | 12.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.75 Mn |
| Mar 31, 2026 | 10.98 Mn |
| Dec 31, 2025 | 3.68 Mn |
| Sep 30, 2025 | 6.02 Mn |
| Jun 30, 2025 | 11.35 Mn |
| Mar 31, 2025 | 8.68 Mn |
| Dec 31, 2024 | 4.69 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | 5.74 Mn |
| Mar 31, 2024 | 2.49 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Sep 30, 2023 | 1.81 Mn |
| Jun 30, 2023 | 1.92 Mn |
| Mar 31, 2023 | 841,000.00 |
| Dec 31, 2022 | 2.20 Mn |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 1.41 Mn |
| Mar 31, 2022 | 1.67 Mn |
| Dec 31, 2021 | 1.07 Mn |
| Sep 30, 2021 | 1.61 Mn |